CONMED Corporation (CNMD)

Market Cap	3.33B
Revenue (ttm)	1.17B
Net Income (ttm)	57.97M
Shares Out	30.75M
EPS (ttm)	1.90
PE Ratio	57.67
Forward PE	25.56
Dividend	$0.80 (0.73%)
Ex-Dividend Date	Dec 15, 2023

Volume	245,005
Open	108.37
Previous Close	108.35
Day's Range	107.53 - 109.79
52-Week Range	82.97 - 138.47
Beta	1.36
Analysts	Strong Buy
Price Target	128.86 (+17.59%)
Earnings Date	Feb 1, 2024

About CNMD

CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for surgical procedures worldwide. It offers orthopedic surgery products, including TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and Agro Knotless Suture Anchors, which provide unique clinical solutions to orthopedic surgeons for the repair of soft tissue injuries, as well as supporting products that enable surgeons to perform minimally invasive sports medicine surgeries. The compan...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: Jul 23, 1987
• Employees: 4,100
• Stock Exchange: NYSE
• Ticker Symbol: CNMD

Analyst Forecast

According to 7 analysts, the average rating for CNMD stock is "Strong Buy." The 12-month stock price forecast is $128.86, which is an increase of 17.59% from the latest price.

Price Target

$128.86

(17.59% upside)

Analyst Consensus: Strong Buy